| Novo Nordisk Pharma AG - Rybelsus 14 mg, Tabletten |
| 67446 | | 03 | | Rybelsus 14 mg | | Tabletten | | A10BJ06 | | Semaglutide | | 24.03.2020 | | |
|
| Composition |
| semaglutidum 14 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum K 90, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Semaglutidum | 14 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Semaglutidum | 14 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Cellulosum Microcristallinum | | | Magnesii Stearas | | | Natrii Salcaprozas | | | Povidonum K | 90 | | Pro Compresso | |
| |
|
|
